Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients With Advanced Lung Adenocarcinoma
Clinical trial NCT06491225 · TERMINATED
Trial details
- NCT number
- NCT06491225
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-18
- Primary completion
- 2024-08-27
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.